AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

COCHLEAR LTD

274.590

+3.7701.39%

Volume:296.51K

Turnover:81.34M

Market Cap:17.96B

PE:48.67

High:275.490

Open:272.150

Low:271.530

Close:270.820

Loading ...

Overview Company News Filings

3 excellent ASX shares I would buy and hold for the next 10 years

Cochlear Limited (ASX:COH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Simply Wall St.

10 best shares to buy today in Australia

Cochlear-backed Epiminder targets 2025 IPO as FDA authorisation lands

The Australian Financial Review

Where to invest $20,000 into ASX 200 shares after the market selloff

5 'particularly interesting' ASX All Ords stocks to buy amid the Trump tariff mayhem

Why this fund manager is buying the dip in BHP shares

Why this ASX share market selloff could be a golden opportunity for investors

Stock Track | Cochlear Ltd Soars 6.09% as Tariff Exemption Shields Company from Trade Tensions

Stock Track | Cochlear Shares Soar 6.09% as Hearing Implants Escape US Tariffs

Trump 2.0: Macquarie's take on the winners and losers in Australian healthcare

Australian Shares Rise Amidst US-Japan Trade Exceptions Hopes; Guzman y Gomez Posts Higher Fiscal Q3 Sales

MT Newswires Live

BUZZ-Australia's Cochlear rebounds from day's losses, addresses U.S. tariffs

Cochlear to Continue to Adopt Duty-Free Arrangement With US on Certain Products

MT Newswires Live

Cochlear set to dodge tariffs while countries’ negotiations with Trump kick off

The Market Herald

Cochlear - Confirms Will Continue to Be Able to Rely on a Chapter of Harmonized Tariff Schedule of United States

THOMSON REUTERS

'This is a great time to get rich': 3 of the best ASX shares to buy

Bookworm: This ASX name meets many of Terry Smith’s criteria

Morning Star AU

Unpleasant Surprises Could Be In Store For Cochlear Limited's (ASX:COH) Shares

Simply Wall St.

Australian Shares Fall as Tariffs Cause Global Selloff; Fisher & Paykel Expects Higher Costs in Fiscal Year 2026

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/COH.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COH.AU\",,,,,undefined,":{"symbol":"COH.AU","market":"AU","secType":"STK","nameCN":"COCHLEAR LTD","latestPrice":274.59,"timestamp":1745993520000,"preClose":270.82,"halted":0,"volume":296511,"delay":0,"nameEN":"COCHLEAR LTD","floatShares":65138291,"shares":65396930,"eps":5.641558,"marketStatus":"Not Yet Opened","change":3.77,"latestTime":"04-30 16:12:00 AEST","open":272.15,"high":275.49,"low":271.53,"amount":81338807,"amplitude":0.014622,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":5.641558,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746057600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":270.82,"dividendRate":0.015478,"openAndCloseTimeList":[[1745971200000,1745992800000]],"volumeRatio":2.1092816354719286,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COH.AU\",,,,,undefined,":{"symbol":"COH.AU","floatShares":65138291,"roa":"12.28%","roe":"20.30%","lyrEps":5.444277,"volumeRatio":2.1092816354719286,"shares":65396930,"dividePrice":4.25,"high":275.49,"amplitude":0.014622,"preClose":270.82,"low":271.53,"week52Low":246.14,"pbRate":"9.62","psRate":"7.78","week52High":344.999,"institutionHeld":0,"latestPrice":274.59,"eps":5.641558,"divideRate":0.015478,"volume":296511,"delay":0,"ttmEps":5.641558,"open":272.15,"prevYearClose":287.567,"prevWeekClose":264.62,"prevMonthClose":274.59,"prevQuarterClose":262.3,"fiveDayClose":260.22,"twentyDayClose":267.32,"sixtyDayClose":317.08},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COH.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531704303","title":"3 excellent ASX shares I would buy and hold for the next 10 years","url":"https://stock-news.laohu8.com/highlight/detail?id=2531704303","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531704303?lang=en_us&edition=fundamental","pubTime":"2025-04-30 16:12","pubTimestamp":1746000772,"startTime":"0","endTime":"0","summary":"In investing, time is your greatest advantage — and quality is your best defence. While short-term trades can grab headlines, it is long-term compounding that builds real wealth. The challenge?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/30/3-excellent-asx-shares-i-would-buy-and-hold-for-the-next-10-years/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["COH.AU","BK7007","BK7153","BK7041","MQG.AU","BK7046","BK7511","WES.AU"],"gpt_icon":0},{"id":"2530103509","title":"Cochlear Limited (ASX:COH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?","url":"https://stock-news.laohu8.com/highlight/detail?id=2530103509","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530103509?lang=en_us&edition=fundamental","pubTime":"2025-04-27 08:09","pubTimestamp":1745712590,"startTime":"0","endTime":"0","summary":"Cochlear  has had a rough three months with its share price down 16%. But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially see an increase in value in the long-term, given how markets usually reward companies with good financial health. Specifically, we decided to study Cochlear's  ROE in this article.ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders.  We check all companies for important risks. See what we found for Cochlear in our. Return on Equity = Net Profit  ÷ Shareholders' Equity. Is Cochlear Making Efficient Use Of Its Profits?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cochlear-limited-asx-coh-stock-000950104.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7007","COH.AU"],"gpt_icon":0},{"id":"2530699258","title":"10 best shares to buy today in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2530699258","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530699258?lang=en_us&edition=fundamental","pubTime":"2025-04-25 06:03","pubTimestamp":1745532180,"startTime":"0","endTime":"0","summary":"Trying to decide where to put your money in this market?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/25/10-best-shares-to-buy-today-in-australia/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU2471134523.USD","LU2237443465.HKD","UNI.AU","NXT.AU","LU2471134796.USD","BK7137","LU1868837136.USD","BK7007","HMC.AU","BK7503","XJO.AU","XKO.AU","LU0048573561.USD","LU2750360641.GBP","BK4533","XAO.AU","DMP.AU","IE0004091025.USD","LU0106831901.USD","LU2237443622.USD","BK4504","RMD.AU","LU1868837300.USD","WTC.AU","BK7062","BK7016","COH.AU","BK7021","TPW.AU","BK7049","IE00B19Z3B42.SGD","BK7107","LU0251142724.SGD","BK4585","LU1868836757.USD","BK4127","BK4516","IE0002270589.USD","IE0004086264.USD","IE00BFXG1179.USD","LU1868836591.USD","BK7043","LU1668664300.SGD","360.AU","LU2237438978.USD","BK7501","LU1791807156.HKD","LU2471134952.CNY","AX1.AU","BK4550"],"gpt_icon":0},{"id":"2529391746","title":"Cochlear-backed Epiminder targets 2025 IPO as FDA authorisation lands","url":"https://stock-news.laohu8.com/highlight/detail?id=2529391746","media":"The Australian Financial Review","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529391746?lang=en_us&edition=fundamental","pubTime":"2025-04-22 11:04","pubTimestamp":1745291040,"startTime":"0","endTime":"0","summary":"Cochlear-backed Epiminder has its sights set on an Australian initial public offering after securing Food and Drug Administration approval for its flagship Minder device.The medtech, which has spent eight years developing its sub-scalp device to detect seizures for epilepsy patients, will announce on Tuesday that it’s received clearance to market its device in the US.Loading...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.afr.com/street-talk/cochlear-backed-epiminder-targets-2025-ipo-as-fda-authorisation-lands-20250422-p5ltcs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"afr_stock","symbols":["COH.AU"],"gpt_icon":0},{"id":"2528473810","title":"Where to invest $20,000 into ASX 200 shares after the market selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2528473810","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528473810?lang=en_us&edition=fundamental","pubTime":"2025-04-19 03:52","pubTimestamp":1745005920,"startTime":"0","endTime":"0","summary":"Market selloffs are rarely pleasant — but for long-term investors, they can be exactly the kind of opportunity that sets the stage for future outperformance. With ASX 200 shares pulling back sharply i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/19/where-to-invest-20000-into-asx-200-shares-after-the-market-selloff/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7107","BK7002","BK7503","BK7007","COH.AU","REA.AU","TPW.AU","BK7049"],"gpt_icon":0},{"id":"2527511133","title":"5 'particularly interesting' ASX All Ords stocks to buy amid the Trump tariff mayhem","url":"https://stock-news.laohu8.com/highlight/detail?id=2527511133","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527511133?lang=en_us&edition=fundamental","pubTime":"2025-04-14 13:12","pubTimestamp":1744607549,"startTime":"0","endTime":"0","summary":"The All Ordinaries Index  is up a welcome 1.38% on Monday, but most ASX All Ords stocks remain well down from the market highs on 14 February. Indeed, the All Ords is still down 9.78% since notching its record closing high on the day. The headwinds that have dragged on global and Aussie stock markets alike since then can largely be pinned on the unpredictable and oft-changing trade policies under United States President Donald Trump. Trump's sweeping global tariffs, in particular, have unsettled investors. This, in turn, sent many ASX All Ords stocks tumbling despite no likely fundamental changes to their long-term prospects. \"We, like almost every other investor on the planet, underestimated Trump's resolve to reshape global trade and just how far he appears willing to go to do this,\" said Jun Bei Liu, founder and lead portfolio manager at Ten Cap . Liu pointed to Trump's 2 April 'Liberation Day' tariff announcement as having \"drastically changed the course of the macroeconomic and in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/14/5-particularly-interesting-asx-all-ords-stocks-to-buy-amid-the-trump-tariff-mayhem/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7002","BK7094","BK7501","REA.AU","BK7503","360.AU","FPH.AU","BK7016","XAO.AU","BK7007","PME.AU","COH.AU"],"gpt_icon":0},{"id":"2527928546","title":"Why this fund manager is buying the dip in BHP shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2527928546","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527928546?lang=en_us&edition=fundamental","pubTime":"2025-04-14 09:23","pubTimestamp":1744593783,"startTime":"0","endTime":"0","summary":"BHP Group Ltd (ASX: BHP) shares have gotten walloped in the early months of the new Donald Trump presidency. Now, the first month of Trump's return to the White House saw a modest uptick for the S&P/A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/14/why-this-fund-manager-is-buying-the-dip-in-bhp-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4585","COH.AU","XAO.AU","BK7095","BHP.AU","BK7507","BK7007","XKO.AU","BK7511","XJO.AU","BHP","BK4168","BK4588"],"gpt_icon":0},{"id":"2526277916","title":"Why this ASX share market selloff could be a golden opportunity for investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2526277916","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526277916?lang=en_us&edition=fundamental","pubTime":"2025-04-12 08:36","pubTimestamp":1744418160,"startTime":"0","endTime":"0","summary":"Let's be honest — market selloffs don't feel like opportunities when they're happening. They feel like chaos. Watching your portfolio turn red and wondering if the market knows something you don't is ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/12/why-this-asx-share-market-selloff-could-be-a-golden-opportunity-for-investors/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["COH.AU","BK7007","BK7503","BK7016","NDQ.AU","TNE.AU"],"gpt_icon":0},{"id":"1199170207","title":"Stock Track | Cochlear Ltd Soars 6.09% as Tariff Exemption Shields Company from Trade Tensions","url":"https://stock-news.laohu8.com/highlight/detail?id=1199170207","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199170207?lang=en_us&edition=fundamental","pubTime":"2025-04-10 08:04","pubTimestamp":1744243467,"startTime":"0","endTime":"0","summary":"Shares of Cochlear Ltd , the Australian hearing implant maker, surged 6.09% during Thursday's trading session, outperforming the broader market. The significant uptick comes as investors react positively to the company's resilient position amid escalating global trade tensions.According to a recent analysis by Macquarie Group, Cochlear has emerged relatively unscathed from the latest round of US tariffs. The company's hearing implants continue to enjoy duty-free treatment under the current US ha","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["COH.AU"],"gpt_icon":0},{"id":"1126093226","title":"Stock Track | Cochlear Shares Soar 6.09% as Hearing Implants Escape US Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=1126093226","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126093226?lang=en_us&edition=fundamental","pubTime":"2025-04-10 08:04","pubTimestamp":1744243466,"startTime":"0","endTime":"0","summary":"Cochlear Ltd  saw its shares surge 6.09% in Thursday's trading session, as investors reacted positively to news that the company's products remain exempt from the latest round of US tariffs. This development comes amid growing concerns about the impact of global trade tensions on the healthcare sector.According to a recent analysis by Macquarie Group, Cochlear's hearing implants continue to enjoy duty-free treatment under the current US harmonized tariff schedule. This exemption shields the comp","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Cochlear Shares Soar 6.09% as Hearing Implants Escape US Tariffs","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["COH.AU"],"gpt_icon":0},{"id":"2526990342","title":"Trump 2.0: Macquarie's take on the winners and losers in Australian healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2526990342","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526990342?lang=en_us&edition=fundamental","pubTime":"2025-04-10 05:12","pubTimestamp":1744233120,"startTime":"0","endTime":"0","summary":"] A key challenge for both RMD and FPH will be negotiations with US payors to increase pricing or widening co-payments. We note upside risk for both names if respiratory devices/apparatus are exempt from tariffs under the Nairobi Protocol implemented through the Harmonised Tariff Schedule.  That said, ResMed isn't completely immune. With part of its manufacturing based in Australia and Singapore, both now facing 10% tariffs, and rising input costs from tariffed raw materials, its earnings forecasts have been trimmed by 2% for FY 2026 and FY 2027. What about CSL and Cochlear?Biotech giant CSL Ltd  escaped the current round of tariffs, thanks to exemptions for pharmaceutical products. However, Macquarie flagged it as a name to watch. It said:  CSL is left unscathed by reciprocal tariffs as pharmaceuticals are exempted. However, potential sector tariffs remain a key risk for CSL in the near term.  As for Cochlear Ltd , it also sidestepped the tariff net, as hearing devices continue to enj","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/10/trump-2-0-macquaries-take-on-the-winners-and-losers-in-australian-healthcare/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["XKO.AU","ANN.AU","BK7508","BK7007","FPH.AU","MQG.AU","BK7126","BK7046","BK7501","BK7511","CSL.AU","XJO.AU","RMD.AU","XAO.AU","BK7067","COH.AU"],"gpt_icon":0},{"id":"2525321268","title":"Australian Shares Rise Amidst US-Japan Trade Exceptions Hopes; Guzman y Gomez Posts Higher Fiscal Q3 Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2525321268","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525321268?lang=en_us&edition=fundamental","pubTime":"2025-04-08 14:37","pubTimestamp":1744094223,"startTime":"0","endTime":"0","summary":"Australian shares rose on Tuesday's close, as Asian markets rebounded from tariff losses, boosted by Japan-US Trade optimism.The S&P/ASX 200 Index rose 2.27% or 166.7 points to close at 7,510.Presiden","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GYG.AU","COH.AU","XAO.AU","XKO.AU","XJO.AU","JHX.AU"],"gpt_icon":0},{"id":"2525801378","title":"BUZZ-Australia's Cochlear rebounds from day's losses, addresses U.S. tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2525801378","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525801378?lang=en_us&edition=fundamental","pubTime":"2025-04-08 12:11","pubTimestamp":1744085509,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Cochlear rebounds from day's losses, addresses U.S. tariffs** Shares of Cochlear COH.AX up 0.4%, recovering from a 2.6% fall earlier in the day** Hearing aid maker says its implants will remain exempt from U.S. import duties.** Shares of co lost ~4% in the past couple of sessions amid recessionary fears, down 12.3% YTD** However, gains of co seen on the day lower than the domestic healthcare stocks' sub-index .AXHJ 2.6% climb","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nL4N3OB0JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COH.AU","BK7007"],"gpt_icon":0},{"id":"2525009224","title":"Cochlear to Continue to Adopt Duty-Free Arrangement With US on Certain Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2525009224","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525009224?lang=en_us&edition=fundamental","pubTime":"2025-04-08 08:43","pubTimestamp":1744073036,"startTime":"0","endTime":"0","summary":"Cochlear  will continue to operate under a duty-free arrangement with the US as it awaits clarity on recent trade developments, the maker of hearing implants said in a Tuesday filing with the Australian bourse.Cochlear is currently under the Harmonized Tariff Schedule of the US that provides duty-free importation on a range of products into the US, including hearing implants, per the filing.The company said it will \"continue to actively monitor and engage in the evolving global landscape\" in line with the imposition of a 10% tariff on exports to the US from Australia.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","XAO.AU","BK7007","COH.AU","XKO.AU"],"gpt_icon":0},{"id":"2525888638","title":"Cochlear set to dodge tariffs while countries’ negotiations with Trump kick off","url":"https://stock-news.laohu8.com/highlight/detail?id=2525888638","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525888638?lang=en_us&edition=fundamental","pubTime":"2025-04-08 08:36","pubTimestamp":1744072560,"startTime":"0","endTime":"0","summary":"Australia’s hearing implant giant Cochlear  has clarified an April 3 release, stating its hearing implants do fall under an exemption clause in Trump’s “Liberation Day” tariffs.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.Hearing implants are ensnared within the existing Harmonized Tariff Schedule  of the U.S. which has provided some relief to companies whose products match that extant regulatory standard.In the company’s own words: “Cochlear confirms it will continue to be able to rely on a chapter of the [HTS] of the United States that provides for duty-free importation on a range of products into the US, including hearing implants.”The phrase “able to rely” is probably what’s most important, given markets are still broadly nervous about how long these tariffs will stay in place for.Levy beef: Trump whacks Oz with 10% tariffs on “Liberation Day”。Perhaps more importantly for Coc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/cochlear-set-to-dodge-tariffs-while-countries-negotiations-with-trump-kick-off-2025-04-08/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7007","COH.AU"],"gpt_icon":0},{"id":"2525600326","title":"Cochlear - Confirms Will Continue to Be Able to Rely on a Chapter of Harmonized Tariff Schedule of United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2525600326","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525600326?lang=en_us&edition=fundamental","pubTime":"2025-04-08 07:48","pubTimestamp":1744069725,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL0X2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","COH.AU"],"gpt_icon":0},{"id":"2525043147","title":"'This is a great time to get rich': 3 of the best ASX shares to buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2525043147","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525043147?lang=en_us&edition=fundamental","pubTime":"2025-04-07 02:13","pubTimestamp":1743963180,"startTime":"0","endTime":"0","summary":"Wall Street has just had one of its worst two-day stretches in years. In fact, it was the biggest two-day decline since the COVID-19 market crash back in 2020. The Dow Jones plunged over 2,200 points ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/07/this-is-a-great-time-to-get-rich-3-of-the-best-asx-shares-to-buy/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["PME.AU","BK7094","BK7503","BK7007","COH.AU","REA.AU","BK7002"],"gpt_icon":0},{"id":"2525072669","title":"Bookworm: This ASX name meets many of Terry Smith’s criteria","url":"https://stock-news.laohu8.com/highlight/detail?id=2525072669","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525072669?lang=en_us&edition=fundamental","pubTime":"2025-04-07 00:00","pubTimestamp":1743955200,"startTime":"0","endTime":"0","summary":"Welcome to the next edition of Bookworm, my column that seeks to share insights from investing and business writing that can make you a better investor. Going forward, this column will be published ev","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/personal-finance/bookworm-this-asx-name-meets-many-terry-smiths-criteria","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["LU0965509283.SGD","LU2750360641.GBP","SG9999003800.SGD","BK4581","LU1032955483.USD","LU1670627923.USD","LU2054465674.USD","SG9999014880.SGD","IE00BN8TJ469.HKD","IE00B3SWFQ91.USD","LU0289739343.SGD","SG9999018857.SGD","LU0053666078.USD","LU0094547139.USD","LU1043141396.HKD","LU2552382058.USD","IE00B4JS1V06.HKD","LU0256863902.USD","LU1935042991.SGD","LU1059921491.USD","LU2089283258.USD","LU2210149790.SGD","COH.AU","LU2092937221.SGD","IE000KEQY171.SGD","IE0005OL40V9.USD","LU1506573853.SGD","LU1235294995.USD","LU0096362180.USD","LU0889566641.SGD","LU2362540622.SGD","LU0170899867.USD","BK4525","IE00BJLML261.HKD","LU2077746001.SGD","BK4534","LU0456855351.SGD","LU1935043536.SGD","LU1934455277.USD","LU0994945656.USD","LU0072462426.USD","PM","LU0528227936.USD","LU2275660780.HKD","LU2247934214.USD","LU2326559502.SGD","LU1035773651.USD","LU1629891620.HKD"],"gpt_icon":1},{"id":"2525269837","title":"Unpleasant Surprises Could Be In Store For Cochlear Limited's (ASX:COH) Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2525269837","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525269837?lang=en_us&edition=fundamental","pubTime":"2025-04-06 06:00","pubTimestamp":1743890425,"startTime":"0","endTime":"0","summary":"Cochlear Limited's ( ASX:COH ) price-to-earnings (or \"P/E\") ratio of 46.1x might make it look like a strong sell right...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/unpleasant-surprises-could-be-in-store-for-cochlear-limiteds","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7007","COH.AU"],"gpt_icon":0},{"id":"2524401615","title":"Australian Shares Fall as Tariffs Cause Global Selloff; Fisher & Paykel Expects Higher Costs in Fiscal Year 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2524401615","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524401615?lang=en_us&edition=fundamental","pubTime":"2025-04-03 14:02","pubTimestamp":1743660127,"startTime":"0","endTime":"0","summary":"Australian shares fell on Thursday's close, tracking Wall Street markets, after Trump implemented hefty tariffs on all imports to the US.The S&P/ASX 200 fell 0.9% or 74.8 points to close at 7,859.7.Th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ANZ.AU","FPH.NZ","XAO.AU","BRG.AU","XJO.AU","ANN.AU","BK7126","COH.AU","XKO.AU","BK7007","BK7135","BK7501","FPH.AU","BK7511","BK7119","BK8004"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":105,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COH.AU\",params:#limit:5,,,undefined,":[{"date":"2025-03-20","symbol":"COH.AU","amount":2.15,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-21","name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-14","payableDate":"2025-03-21","currency":"AUD","dateTimestamp":1742389200000,"payDate":"2025-04-14"},{"date":"2025-02-13","symbol":"COH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739401200000,"name":null,"time":"","dateTimestamp":1739365200000,"actualEps":null},{"date":"2024-09-17","symbol":"COH.AU","amount":2.1,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-18","defaultRemindTime":1726531200000,"name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-10","payableDate":"2024-09-18","currency":"AUD","dateTimestamp":1726495200000,"payDate":"2024-10-10"},{"date":"2024-08-15","symbol":"COH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723680000000,"name":null,"time":"","dateTimestamp":1723644000000,"actualEps":null},{"date":"2024-03-21","symbol":"COH.AU","amount":2,"announcedDate":"2024-02-19","type":"dividend","market":"AU","newRecordDate":"2024-03-22","defaultRemindTime":1710975600000,"name":"科利耳有限公司","recordDate":"2024-04-15","payableDate":"2024-03-22","currency":"AUD","dateTimestamp":1710939600000,"payDate":"2024-04-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COH.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2021-03-25","recordDate":"2021-03-26","paymentDate":"2021-04-20","value":1.15,"currency":"AUD"},{"executeDate":"2021-09-23","recordDate":"2021-09-24","paymentDate":"2021-10-18","value":1.4,"currency":"AUD"},{"executeDate":"2022-03-28","recordDate":"2022-03-29","paymentDate":"2022-04-21","value":1.55,"currency":"AUD"},{"executeDate":"2022-09-21","recordDate":"2022-09-23","paymentDate":"2022-10-17","value":0.87,"currency":"AUD"},{"executeDate":"2023-03-21","recordDate":"2023-03-22","paymentDate":"2023-04-14","value":1.0075,"currency":"AUD"}]}}